Why the study?
Does cardiac resynchronization therapy improve long-term clinical outcomes and device performance in patients with drug-refractory heart failure?
Does cardiac resynchronization therapy improve long-term clinical outcomes and device performance in patients with drug-refractory heart failure?
Answers are grounded in this paper and cite their sources.
Cardiac resynchronization therapy provides sustained improvements in functional class, exercise capacity, and quality of life over 3 years in patients with drug-refractory heart failure.
AIMS: To evaluate the long-term clinical outcome and device performance of cardiac resynchronization therapy in a consecutive sample of patients with moderate to severe heart failure. METHODS AND RESULTS: Between 1998 and 2000, forty consecutive patients with drug-refractory heart failure due to ischemic or idiopathic dilated cardiomyopathy were selected for cardiac resynchronization therapy (CRT). After successful implantation of the coronary sinus lead (n = 35, 88%), patients were followed every sixth month by New York Heart Association (NYHA) functional class, the 6-minute walking test (6 walk), quality of life (QoL, Minnesota), and pacemaker control. NYHA-class and 6 walk were significantly improved after 6 months and continued to improve gradually until 36 months of follow-up. The QoL improvement at 6 months was sustained over 3 years. After 3 years, the beta-blocker dose could be increased in 10/23 patients as compared to baseline. Nine patients had to be re-operated. Coronary sinus lead thresholds were stable over time. CONCLUSION: The clinical improvements by CRT are sustained over 3 years of follow-up. In the setting of a University Medical Center, CRT can be applied in clinical routine with excellent clinical outcome, acceptable implantation success, and stable device performance over time.
No takes yet. Share an insight, caveat, or question.
Ståhlberg et al. (2005) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: